If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Baricitinib
Olumiant® (baricitinib) tablets
1mg, 2mg, 4mgbaricitinib
1mg, 2mg, 4mgThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
How is Olumiant® (baricitinib) supplied and how should it be stored?
Olumiant is supplied as debossed, film-coated, tablets in 1 mg, 2 mg, and 4 mg strengths. Store tablets at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).
See important safety information, including boxed warning, in the attached prescribing information.
How Supplied
Olumiant for oral administration is available as debossed, film-coated, tablets. Each tablet contains a recessed area on each face of the table surface.1 See Description of Olumiant (baricitinib) Tablets for description details.
Description |
Olumiant 1 mg tablet |
Olumiant 2 mg tablet |
Olumiant 4 mg tablet |
Color |
Very light pink |
Light pink |
Medium pink |
Shape |
Round |
Oblong |
Round |
Identification on tablet surface sides |
"Lilly" |
"Lilly" |
"Lilly" |
Bottle count |
30 |
30 |
30 |
NDC |
0002-4732-30 |
0002-4182-30 |
0002-4479-30 |
Abbreviations: NDC = National Drug Code.
Storage and Handling
Store tablets at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).1
Keep out of reach of children.1
Enclosed Prescribing Information
Reference
1Olumiant [package insert]. Indianapolis, IN: Eli Lilly and Company; 2022.
Date of Last Review: August 11, 2023